First Patient Treated in Ongoing Trial for Systemic Sclerosis Drug
According to a publication from Scleroderma News, the first patient in the study of experimental cutaneous systemic sclerosis (SSc) drug AVID200 has been enrolled in the ongoing phase 1b clinical…